UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001220 |
|---|---|
| Receipt number | R000001462 |
| Scientific Title | Phase II study of rituximab containing induction chemotherapy (R-high-CHOP followed by CHASER) and high-dose chemotherapy (LEED) supported with auto-PBSCT for previously untreated patients with advanced mantle cell lymphoma(JCOG0406) |
| Date of disclosure of the study information | 2008/06/30 |
| Last modified on | 2022/08/30 17:30:51 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/06/30 10:01:23 | ||
| 2 | Update | 2009/08/11 16:07:18 | Name of person sending information Name of person sending information Division name Division name |
|
| 3 | Update | 2010/01/22 11:07:21 | Recruitment status |
|
| 4 | Update | 2010/01/22 11:07:51 | Institutions |
|
| 5 | Update | 2010/09/02 11:38:22 | Organization |
|
| 6 | Update | 2011/08/03 13:16:05 | Last name of lead principal investigator Last name of contact person Name of person sending information Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 7 | Update | 2012/05/07 18:40:23 | Institutions |
|
| 8 | Update | 2012/06/20 11:47:01 | Acronym Acronym |
|
| 9 | Update | 2013/03/26 17:53:16 | Recruitment status |
|
| 10 | Update | 2022/08/30 17:30:51 | Recruitment status Date of IRB |
